Introduction
Breast cancer, a malignant neoplasm that poses a serious threat to the health of women, is on the rise globally. The presence of breast cancer not only causes physical suffering, but also has far-reaching psychological and social consequences. Early detection and active treatment are essential to improving the survival of patients. However, patients often face a series of adverse reactions during treatment. Breast cancer is treated in a variety of ways, including surgery, chemotherapy, decomposition, endocrine treatment and target treatment. While these treatments play an important role in the fight against cancer cells, they may at the same time result in different levels of adverse effects on patients. Next, we will look at the negative effects of breast cancer treatment.
II. Types of common adverse effects of breast cancer treatment
(i) Targeting to treat drug side effects
Breast cancer is targeted at a wide range of treatment drugs, with different drug side effects. Single cloned antibodies, such as tutoballs, have common side effects such as headaches, nausea, vomiting, cold and diarrhoea, and some patients may have fever, infection, insomnia, etc. The most common side effects of the anti-HER-2 micromolecular pharmacophagus in the Cortini Clinic are gastrointestinal responses, which can lead to diarrhoea and abdominal pain. CDK4/6 Depressants, such as Pappasili, may be reduced to varying degrees by neutral particle cells and white cells, with patients showing negative reactions such as nausea, fatigue and diarrhoea. In addition, breast cancer-targeting drugs can lead to severe heart failure, pain and swelling in the injection area, skin failure, hair loss, nausea, inactivity, reduction of neutral particle cells, vomiting, white cells and the reduction of particle cells, urine protein, increased blood pressure, hand and foot syndrome, noise and severe upper digestive haemorrhage.
(ii) Post-chemical side effects
The gastrointestinal insufficiency is manifested in vomiting, declining appetite, diarrhoea, constipation, etc. This is due to the damage to gastrointestinal mucous membranes caused by chemotherapy, which led to these adverse reactions. Osteo marrow inhibition and appearance of white color, lack of strength and fatigue. Patients tend to show a decrease in the blood pattern of white cells, meso-particle cells or slabs, thus preventing subsequent infections and treating them with drugs such as white needles and Likogu, if necessary, and blood transfusions. The liver and kidney function is impaired with abdominal swelling, reduced appetite and yellowing. The main manifestations are abdominal swelling, declining appetite, yellowing of the body, yellowing of the eyes, yellowing of the urine, pain in the upper right abdomen, etc. Heart toxicity, manifested in panic, chest depression, etc. Symptoms such as panic, chest distress, short breath, suffocation and discomfort in the front of the heart. Your hair’s gone, your hair’s gone much, even completely. This is one of the side effects common to chemotherapy, but after chemotherapy the hair can recover. Peripheral neurological damage, symptoms of numbness, pain, etc. Symptoms such as numbness, pain, sensory disorders, epilepsy, paralysis, paralysis, confusion, etc.
(iii) Endocrine treatment drug response
The tide, which can be mitigated by relaxing therapy, is treated with medication in severe cases. Osteoporosis, regular detection of bone density, calcium supplementation and vitamin D. The use of aromatic enzyme inhibitors in endocrine treatment can affect osteoporosis, fractures and other side effects. The utero endometrium is thick enough to allow for the use of triphenylamine-type drugs, low-fat diets, etc. In the case of breast cancer endocrine treatment, the use of his mosaics is irritating the uterine membrane, and is prone to co-effects such as increased uterine membranes, increased blubber, and haemorrhage. There is no need to worry too much about the increase in uterine membrane if you take his moxiphine. If the uterus thickness exceeds 19 mm, it requires attention and may require medical intervention.
III. METHODOLOGY TO RESPONSE TO A DIMENSION
In the course of breast cancer treatment, in the event of an adverse reaction, the patient should report to the doctor in a timely manner so that he or she can be properly treated under his or her supervision.
Different measures can be taken depending on the severity of gastrointestinal disorders such as vomiting. Unnecessary special treatment is not required for mild gastrointestinal malformations that do not affect food consumption; in cases of severe gastrointestinal malformations such as nausea, vomiting, i.e., intravenous administration of methoxychloropamine, Ontanszjun, Glaszjan, etc., or oral administration of some antiseptic tablets such as Ontansion, etc., combined application of drugs such as phenyramin, isopropazine, etc., can be considered for stopping or substitution.
In the case of bone marrow inhibition, blood-upgrading drugs, such as white cell counts of less than 3.0 and greater than 2.0, can be treated orally with white radon-upper tablets and licorical tablets; if the white cell count is less than 2.0 or is associated with a fever, a recombinant human particle-stimulator subcutaneous injection is required for treatment with blood transfusion if necessary.
For the side-response of endocrine-treated drugs, tidal fever can be mitigated by relaxing therapy, such as deep breath, relaxation of entire muscles, reduction of psychoactiveness and, in the case of serious cases, medication; osteoporosis should regularly detect bone density, supplemented with calcium and vitamin D under medical supervision; and uterine-enpertominal hemorrhage is clearly drug-induced and can be used, under medical supervision, as an endocrine-based drug, to prevent uterine cancer, with regular attention to low fat diets, weight control, diabetes control.
In any event, in case of an adverse reaction during treatment, the patient must communicate with the doctor in a timely manner and, under his or her guidance, conduct a scientifically sound treatment to improve the effectiveness of the treatment and the quality of life.
Concluding remarks
The treatment of breast cancer, while challenging, must not be deterred by adverse reactions. In the face of possible adverse reactions such as targeted treatment, chemotherapy, endocrine treatment, and so forth, courageous communication with doctors and active cooperation are key to combating disease.
Every patient of breast cancer is a warrior of life and may suffer from a lot of discomfort on the path to fighting the disease, but believe that medicine is advancing and doctors will do their best to provide the best treatment and response.
The adverse effects of nausea, vomiting, hair loss, bone marrow inhibition may cause pain and frustration, but it is only temporary. These difficulties can be overcome only if there is firm confidence and active cooperation with the doctor ‘ s treatment advice and a scientifically sound response.
The patients must remain optimistic and believe that they have enough power to overcome the disease. At the same time, the support of families and friends is crucial, and their company and encouragement give patients more courage and motivation.
Let us work together to refuel for those who have breast cancer, to encourage them to face up to the adverse effects of treatment and to move resolutely towards rehabilitation. It is believed that in the near future every breast cancer patient will be able to live a healthy and good life.
